Crestone, Inc.
Dba Crestone Inc
CAGE Code: 5RDJ6
NCAGE Code: 5RDJ6
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 015881952
Summary
Crestone, Inc., Dba Crestone Inc is an Active Commercial Supplier with the Cage Code 5RDJ6 and is tracked by Dun & Bradstreet under DUNS Number 015881952..
Address
6075 Longbow Dr
Ste 130
Boulder CO 80301-3275
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Technology Applications, Inc. Analytical Imaging And Geophysics Nielsen Dave Ltd Levy, Arthur J Harvard Business Review Inc Technet Inc S A Electronics Inc Lavender Procurement Group Llc Double T Designs Llc Perdix, Inc. Bosonics Inc Microsoft Developer Network Affil Of Freewave Technologies Inc Viserion Grain, Llc Frikgeek Llc U S Dept Of Interior Wildwasser Sport Usa Inc Vacuum Inc Ultimite Direction Inc Informed Access Systems Inc
Frequently Asked Questions (FAQ) for CAGE 5RDJ6
- What is CAGE Code 5RDJ6?
- 5RDJ6 is the unique identifier used by NATO Organizations to reference the physical entity known as Crestone, Inc. Dba Crestone Inc located at 6075 Longbow Dr, Ste 130, Boulder CO 80301-3275, United States.
- Who is CAGE Code 5RDJ6?
- 5RDJ6 refers to Crestone, Inc. Dba Crestone Inc located at 6075 Longbow Dr, Ste 130, Boulder CO 80301-3275, United States.
- Where is CAGE Code 5RDJ6 Located?
- CAGE Code 5RDJ6 is located in Boulder, CO, USA.
Contracting History for CAGE 5RDJ6 Most Recent 25 Records
- 36C25923P1093
- Synthesis And Testing Of Novel Antibiotic Chemical Compounds For Rocky Mountain Regional Va Medical Center Research Department
- 17 Aug 2023
- Synthesis And Testing Of Novel Antibiotic Chemical Compounds For Rocky Mountain Regional Va Medical Center Research Department
- Network Contract Office 19 (36C259)
- Department Of Veterans Affairs (Va)
- $102,140.00
- Department Of Veterans Affairs (Va)
- 75N93020C00020
- To Advance A Promising, Small-Molecule Compound Crs0540 To Ind Filing And Through Phase I Clinical Studies.
- 29 Sep 2022
- To Advance A Promising, Small-Molecule Compound Crs0540 To Ind Filing And Through Phase I Clinical Studies.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $13,310,178.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00020
- To Advance A Promising, Small-Molecule Compound Crs0540 To Ind Filing And Through Phase I Clinical Studies.
- 23 Sep 2021
- To Advance A Promising, Small-Molecule Compound Crs0540 To Ind Filing And Through Phase I Clinical Studies.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $3,717,345.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00020
- To Advance A Promising, Small-Molecule Compound Crs0540 To Ind Filing And Through Phase I Clinical Studies.
- 23 Jan 2023
- To Advance A Promising, Small-Molecule Compound Crs0540 To Ind Filing And Through Phase I Clinical Studies.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $13,310,178.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00020
- Eo14042 - To Advance A Promising, Small-Molecule Compound Crs0540 To Ind Filing And Through Phase I Clinical Studies.
- 10 Dec 2021
- Eo14042 - To Advance A Promising, Small-Molecule Compound Crs0540 To Ind Filing And Through Phase I Clinical Studies.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $7,400,700.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00020
- To Advance A Promising, Small-Molecule Compound Crs0540 To Ind Filing And Through Phase I Clinical Studies.
- 20 Sep 2022
- To Advance A Promising, Small-Molecule Compound Crs0540 To Ind Filing And Through Phase I Clinical Studies.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $13,169,401.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00020
- To Advance A Promising, Small-Molecule Compound Crs0540 To Ind Filing And Through Phase I Clinical Studies.
- 31 Aug 2023
- To Advance A Promising, Small-Molecule Compound Crs0540 To Ind Filing And Through Phase I Clinical Studies.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $15,976,042.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00056
- To Perform The Evaluation Of Safety And Efficacy Of Crs3123 To Treat Clostridium Difficile Infections.
- 21 Jul 2021
- To Perform The Evaluation Of Safety And Efficacy Of Crs3123 To Treat Clostridium Difficile Infections.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $15,413,278.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00056
- To Perform The Evaluation Of Safety And Efficacy Of Crs3123 To Treat Clostridium Difficile Infections.
- 20 Sep 2022
- To Perform The Evaluation Of Safety And Efficacy Of Crs3123 To Treat Clostridium Difficile Infections.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $19,932,897.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00056
- To Perform The Evaluation Of Safety And Efficacy Of Crs3123 To Treat Clostridium Difficile Infections.
- 23 Jan 2023
- To Perform The Evaluation Of Safety And Efficacy Of Crs3123 To Treat Clostridium Difficile Infections.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $19,932,897.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00056
- To Perform The Evaluation Of Safety And Efficacy Of Crs3123 To Treat Clostridium Difficile Infections.
- 20 Jul 2023
- To Perform The Evaluation Of Safety And Efficacy Of Crs3123 To Treat Clostridium Difficile Infections.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $23,443,941.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00056
- To Perform The Evaluation Of Safety And Efficacy Of Crs3123 To Treat Clostridium Difficile Infections.
- 28 Feb 2022
- To Perform The Evaluation Of Safety And Efficacy Of Crs3123 To Treat Clostridium Difficile Infections.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $15,413,278.00
- Department Of Health And Human Services (Hhs)